Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Biologic lung volume reduction therapy for advanced homogeneous emphysema.

Y Refaely¹, M Dransfield, M R Kramer

¹Division of Cardiothoracic Surgery, Rabin Medical Center, Tel Aviv, Israel. Yaelre2@clalit.org

The European Respiratory Journal

|November 21, 2009

Summary

Biologic lung volume reduction (BioLVR) shows promise for advanced emphysema. High-dose BioLVR improved gas trapping and patient outcomes, suggesting a safe and effective treatment option.

Related Concept Videos

Respiratory Volumes

Respiratory Volumes

Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Analysis of adverse drug reactions reported at a teaching hospital in 2023-24.

Journal of postgraduate medicine·2026

Same author

A "fat chance" it's malignant: lipoid pneumonia simulating lung cancer on PET scan.

BMJ case reports·2025

Same author

Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.

The Journal of the Association of Physicians of India·2024

Same author

Role of Bisoprolol in Heart Failure Management: A Consensus Statement from India.

The Journal of the Association of Physicians of India·2024

Same author

Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from India.

The Journal of the Association of Physicians of India·2024

Same author

A method for the infectivity discrimination of enveloped DNA viruses using palladium compounds pre-treatment followed by real-time PCR.

Polish journal of veterinary sciences·2023

Area of Science:

Pulmonology
Biologic Therapies
Emphysema Treatment

Background:

Advanced homogeneous emphysema presents significant treatment challenges.
Current therapies offer limited efficacy for severe cases.
Biologic lung volume reduction (BioLVR) is an emerging therapeutic approach.

Purpose of the Study:

To evaluate the safety and efficacy of BioLVR in patients with advanced homogeneous emphysema.
To compare the outcomes of low-dose (LD) versus high-dose (HD) BioLVR therapy.
To assess the impact of BioLVR on lung function, exercise capacity, and quality of life.

Main Methods:

Phase 2, open-label study involving 25 patients with homogeneous emphysema.
Bronchoscopic administration of BioLVR: LD (10 mL/site) and HD (20 mL/site) at eight subsegments.

More Related Videos

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

Related Experiment Videos

Last Updated: Jun 18, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

Safety assessed via medical complications; efficacy evaluated through gas trapping, spirometry, diffusing capacity, exercise capacity, dyspnoea, and quality of life measures over 6 months.

Main Results:

No deaths or serious medical complications were reported, indicating a favorable safety profile.
High-dose BioLVR demonstrated a statistically significant reduction in gas trapping at 3 months.
At 6 months, HD BioLVR showed superior improvements in lung function (FEV1, FVC), gas trapping, dyspnoea, and quality of life compared to LD therapy.

Conclusions:

Biologic lung volume reduction (BioLVR) therapy, particularly at a high dose of 20 mL per site, appears to be a safe and effective treatment for advanced homogeneous emphysema.
The findings support further investigation of HD BioLVR as a potential therapeutic option for this patient population.
BioLVR offers a novel approach to managing severe emphysema by targeting lung volume reduction.